Scottish Cancer Registry (SMR06)

Preview of JSON file

{
  "required": {
    "gatewayId": "79",
    "gatewayPid": "01ba5dd7-201e-4006-bc92-9665a8f0f698",
    "issued": "2024-10-08T11:28:20.471Z",
    "modified": "2024-10-08T11:28:20.471Z",
    "version": "10.0.0",
    "revisions": [
      {
        "version": "1.0.0",
        "url": "https://web.prod.hdruk.cloud//dataset/79?version=1.0.0"
      }
    ]
  },
  "summary": {
    "abstract": "Public Health Scotland is responsible for the collection of information on Scottish residents when they are diagnosed with malignant (and some benign) tumours.",
    "contactPoint": "phs.edris@phs.scot",
    "keywords": "Cancer",
    "datasetType": "Health and disease",
    "datasetSubType": "Not applicable",
    "populationSize": -1,
    "description": "The registry began in 1958 collecting personal, demographic and diagnosis information (such as site, histology, behaviour, histological confirmation and hospital of diagnosis) from cancer patients. In 1997, a new electronic cancer recording system was launched and at this point the registry was extended to include extra information on tumour stage (for breast, cervical and colorectal cancer), tumour grade and treatment information. A wide variety of geographical data is also included in the dataset including Scottish Index of Multiple Deprivation and Carstairs measures, census output area, NHS Board, Electoral Ward and Parliamentary constituency.",
    "shortTitle": "Scottish Cancer Registry (SMR06)",
    "title": "Scottish Cancer Registry (SMR06)",
    "publisher": {
      "name": "Public Health Scotland",
      "gatewayId": "07"
    },
    "inPipeline": "Available"
  },
  "coverage": {
    "spatial": "United Kingdom,Scotland",
    "typicalAgeRange": "0-150"
  },
  "provenance": {
    "origin": {
      "imageContrast": "Not stated"
    },
    "temporal": {
      "startDate": "1981-01-01T00:00:00Z",
      "timeLag": "More than 6 months",
      "accrualPeriodicity": "Annual",
      "distributionReleaseDate": "2020-08-31T23:00:00Z"
    }
  },
  "accessibility": {
    "access": {
      "deliveryLeadTime": "Variable",
      "jurisdiction": "GB-GBN",
      "dataController": "Public Health Scotland",
      "dataProcessor": "National Services Scotland",
      "accessRights": "https://publichealthscotland.scot/services/data-research-and-innovation-services/electronic-data-research-and-innovation-service-edris/services-we-offer/",
      "accessService": "Scottish National Safe Haven / Trusted Research Environment: https://publichealthscotland.scot/services/data-research-and-innovation-services/electronic-data-research-and-innovation-service-edris/national-safe-haven-nsh/",
      "accessRequestCost": "https://publichealthscotland.scot/services/data-research-and-innovation-services/electronic-data-research-and-innovation-service-edris/cost-of-services/",
      "accessServiceCategory": "TRE/SDE"
    },
    "usage": {
      "dataUseLimitation": "General research use",
      "resourceCreator": {
        "name": "Public Health Scotland"
      }
    },
    "formatAndStandards": {
      "vocabularyEncodingSchemes": "NHS SCOTLAND NATIONAL CODES",
      "conformsTo": "OMOP",
      "languages": "en",
      "formats": "text/csv"
    }
  },
  "linkage": {
    "associatedMedia": "https://www.researchdata.scot/media/gz1lpmk2/scottish-cancer-registry-smr06-variables.pdf"
  },
  "observations": [
    {
      "observedNode": "Events",
      "measuredValue": 1090594,
      "observationDate": "2021-01-16T00:00:00Z",
      "measuredProperty": "count",
      "disambiguatingDescription": "Episodes"
    }
  ],
  "structuralMetadata": [
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_OF_BIRTH",
          "sensitive": false,
          "description": "Date of birth"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "AGE_IN_YEARS",
          "sensitive": false,
          "description": "Age at incidence date"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "AGE_IN_MONTHS",
          "sensitive": false,
          "description": "Age in months"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "SEX",
          "sensitive": false,
          "description": "1 = male, 2 = female"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "ETHNIC_GROUP",
          "sensitive": false,
          "description": "Optional"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_OF_DEATH",
          "sensitive": false,
          "description": "Date of death"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_1",
          "sensitive": false,
          "description": "Underlying cause of death, format ICD10"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_2",
          "sensitive": false,
          "description": "Secondary cause of death 1"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_3",
          "sensitive": false,
          "description": "Secondary cause of death 2"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_4",
          "sensitive": false,
          "description": "Secondary cause of death 3"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_5",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Secondary Cause of death indicates other causes of death. Obtained through NRS linkage and are coded ICD9 until 31.12.1999 (date of death). Deaths from 1.1.2000 are coded in ICD10"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_6",
          "sensitive": false,
          "description": "As above"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_7",
          "sensitive": false,
          "description": "As above"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CAUSE_8",
          "sensitive": false,
          "description": "As above"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DEATH_CERTIFICATE_INITIATED",
          "sensitive": false,
          "description": "Death certificate initiated indicates that the case has FIRST come to light ONLY as a result of a death. However, subsequent evidence may be discovered ‘out in the field’\n0 = No \n1 = Yes\n9= Not Known"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DEATH_CERTIFICATE_ONLY",
          "sensitive": false,
          "description": "This indicates that the case has been registered from the death certificate only, since no other evidence of the tumour can be found\n0 = No \n1 = Yes\n9= Not Known"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_OF_REG",
          "sensitive": false,
          "description": "The date the Registration Officer enters the tumour details on the registry computer and has signed it off as complete (all mandatory fields). This is also sometimes known as Date Record First Confirmed."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "INCIDENCE_DATE",
          "sensitive": false,
          "description": "Date of incidence"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "SIDE",
          "sensitive": false,
          "description": "This indicates the side or Laterality (i.e. left or right) In paired organs of the body in which the tumour is located. It is important that this be recorded for paired organs (e.g. breast, kidney, limb, lung, ovary, testis)."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "ICD10S_CANCER_SITE",
          "sensitive": false,
          "description": "The anatomical site of origin of the primary tumour, format ICD10"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "ICDO2_ICDO2",
          "sensitive": false,
          "description": "The anatomical site of origin of the primary tumour, format ICDO2"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TYPE_ICDO",
          "sensitive": false,
          "description": "ICDO - International Classification of Diseases for Oncology.  Tumour type indicates the morphology (histology) of the tumour and comprises the first four digits of the ICD-O morphology code and a fifth digit which denotes behaviour of the tumour.. \nAll registrations with an incidence date up to and including 31.12.1996 should be classified according to the ICDO classification.  \n5th digit options:[0] Benign [1] Uncertain whether benign or malignant  [2]  Carcinoma in situ [3]  Malignant- primary site \n[6]  Malignant- metastatic site or secondary site [9]  Malignant- uncertain whether primary or metastatic site"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "MORPH_MORPHOLOGY",
          "sensitive": false,
          "description": "ICD(O)2 - International Classification of Diseases for Oncology (2nd revision). Tumour type indicates the morphology (histology) of the tumour and comprises the first four digits of the ICDO(2) morphology code and a fifth digit which denotes behaviour. All registrations with an incidence date from 1.1.1997 to 31.12.2005 should now be completed with an ICD(O)2 morphology code. There are some differences between ICDO and  ICDO(2) including the change in behaviour of certain tumour types from  one classification to the other."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TYPE_ICDO3",
          "sensitive": false,
          "description": "The morphology (histology) of the tumour, comprising of the first four digits of the ICDO(3) morphology code and a fifth digit which denotes behaviour. This field will be completed for all registrations with an incidence date from 1.1.2006."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "GRADE_CLASSIFICATION",
          "sensitive": false,
          "description": "Indicates the classification system used for grading tumour"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "GRADE_CELL_TYPE",
          "sensitive": false,
          "description": "Grade or cell type indicates the degree of differentiation of malignant tumours or the T-cell & B-cell designation for lymphomas and leukaemias."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "MVB_DIAG",
          "sensitive": false,
          "description": "Most valid base of diagnosis: indicates the method judged to have provided or validated the diagnosis during the course of the illness."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HIST_VER",
          "sensitive": false,
          "description": "Histological Verification: microscopic confirmation of the histological or cytological diagnosis (including examination of peripheral blood film)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "METHOD_1ST_DETECTION",
          "sensitive": false,
          "description": "Method of first detection indicates how the tumour was first detected."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_CLINICAL_T",
          "sensitive": false,
          "description": "Clinical stage indicates the extent of spread of the tumour at diagnosis in terms of clinical findings.\nStage is associated with invasive tumours only.\nT-size/ Extent of Primary tumour based on clinical examination ± imaging, e.g. mammography."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_CLINICAL_N",
          "sensitive": false,
          "description": "Condition of regional lymph nodes/glands based on clinical examination ± imaging"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_CLINICAL_M",
          "sensitive": false,
          "description": "Indicates distant metastases."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_PATHOLOGIC_T",
          "sensitive": false,
          "description": "Pathological Stage indicates the extent of the spread of the tumour at diagnosis in terms of the pathological findings.\nBreast and lung will be collected from incidence 01/01/2005. Renal and prostate will be collected from 01/01/2013\nStage is associated with invasive tumours only.\nT-size/ Extent of Primary tumour based on clinical examination ± imaging, e.g. mammography."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_PATHOLOGIC_N",
          "sensitive": false,
          "description": "Condition of regional lymph nodes/glands based on clinical examination ± imaging"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_PATHOLOGIC_M",
          "sensitive": false,
          "description": "Indicates distant metastases."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CLINICAL_EXTENT_OF_DISEASE",
          "sensitive": false,
          "description": "Clinical Extent of Disease is collected for invasive lung tumours of 01/01/2005 incidence data.\nIndicates the extent of spread of invasive lung tumour."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_COLORECTAL",
          "sensitive": false,
          "description": "Dukes' stage (colorectal): indicates the extent of spread of the invasive tumour at diagnosis in terms of the pathological and/or clinical findings for Socrates. Extent of Primary tumour for Colorectal cancer - Dukes’ staging is primarily based on histological findings."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_FIGO_AFTER_SURGERY",
          "sensitive": false,
          "description": "FIGO Stage indicates the extent of spread of the invasive primary tumour for Cervix and ovary at diagnosis in terms of the pathological and/or clinical findings.\nFrom 01/01/1997  FIGO stage will be collected for invasive tumours of the cervix. From 01/01/2005 incidence date FIGO stage will also be collected for invasive tumours of the ovary."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGE_FIGO_BEFORE_SURGERY",
          "sensitive": false,
          "description": "FIGO Stage indicates the extent of spread of the invasive primary tumour for Cervix and ovary at diagnosis in terms of the pathological and/or clinical findings. FIGO stage will be collected for all tumours of the cervix and ovary from an incidence date of 01/01/2005."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TUMOUR_SIZE",
          "sensitive": false,
          "description": "Pathological tumour size: the maximum diameter in mm of the invasive component of the tumour in the fresh or fixed state on the histological preparation.  If the two measurements are discrepant then that obtained from the histological (fixed) section(s) should be recorded. The tumour (not the excised specimen) with the greatest diameter should be used. This is collected for invasive breast tumours only. Range 000-999 or NK - not known."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "NODES_EXAMINED",
          "sensitive": false,
          "description": "Pathological nodal status -Indicates if the regional lymph nodes were examined. Associated with invasive breast cancer only."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "NO_OF_NODES_EXAMINED",
          "sensitive": false,
          "description": "Pathological nodal status -Indicates how many of the regional lymph nodes were examined"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "POSITIVE_NODES",
          "sensitive": false,
          "description": "Pathological nodal status: indicates if any of the regional lymph nodes were positive."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "NO_POSITIVE_NODES",
          "sensitive": false,
          "description": "Pathological nodal status -Indicates how many of the regional lymph nodes were positive"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "SURGERY",
          "sensitive": false,
          "description": "Indicates if the patient has been treated with surgery"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_SURGERY",
          "sensitive": false,
          "description": "Date of first surgical treatment"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "REF_TO_RAD",
          "sensitive": false,
          "description": "Referred to radiotherapy department"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TREATED_WITH_RAD",
          "sensitive": false,
          "description": "Indicates if the patient has been treated with radiotherapy. Codes as per 'Surgery'."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "RAD_TO_PRIMARY",
          "sensitive": false,
          "description": "Radiotherapy treatment to Primary site."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "RAD_TO_METS",
          "sensitive": false,
          "description": "Radiotherapy treatment to Metastases."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "RAD_OTHER",
          "sensitive": false,
          "description": "Radiotherapy treatment Other such as organ ablation or prophylaxis."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_RAD",
          "sensitive": false,
          "description": "Date of first Radiotherapy treatment"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CHEMO",
          "sensitive": false,
          "description": "Indicates if the patient has had Systemic chemotherapy treatment. Codes as per 'Surgery'."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_CHEMO",
          "sensitive": false,
          "description": "Date of first Chemotherapy"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HORM_THERAPY",
          "sensitive": false,
          "description": "Indicates if the patient has had Hormone treatment. Codes as per 'Surgery'."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_HORM",
          "sensitive": false,
          "description": "Date of first Hormone Therapy"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "OTHER_THERAPY",
          "sensitive": false,
          "description": "Other Therapy. Codes as per 'Surgery'."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TYPE_OTHER_THERAPY",
          "sensitive": false,
          "description": "Indicates the type of other therapy treatment carried out.\nOther therapy examples:\nCryotherapy/cold coagulation, Diathermy, Laser therapy\nImmunotherapy or Biotherapy\nTransfusion, Stem cell support, Venesection"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_OTHER_THERAPY",
          "sensitive": false,
          "description": "Date of other Therapy"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "VITAL_STATUS",
          "sensitive": false,
          "description": "1 = Alive \n2 = Dead \n3 = Moved to England or Wales \n4 = Moved to Northern Ireland \n5 = Emigrated Abroad\n9 = Not known  ( e.g. flag if over 100 years old & has no date of death)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "EMBARKATION_DATE",
          "sensitive": false,
          "description": "This is the date of emigration from Scotland. \nRecorded from 1997 onwards"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "MELANOMA_SKIN_BRESLOW_SIZE",
          "sensitive": false,
          "description": "This is collected for registrations of cutaneous malignant melanoma. This is a measure of the depth of invasion of the melanoma into the skin in mm."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "MELANOMA_SKIN_CLARKS_LEVEL",
          "sensitive": false,
          "description": "This is a measure of depth of invasion of the melanoma into the skin."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DEATH_OUT_OF_SCOTLAND",
          "sensitive": false,
          "description": "Death out of Scotland. Y = Yes"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "MICROINVASIVE",
          "sensitive": false,
          "description": "The term ‘microinvasive’ is used to describe a degree of invasion which is not associated with any risk of nodal metastasis and is sufficiently small to treat by local or conservative means."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HER2",
          "sensitive": false,
          "description": "Herceptin receptor status. Record status regardless of any qualifying statements, e.g. weakly positive. This is collected for invasive breast tumours only."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "PROGESTERONE_RECEPTOR_STATUS",
          "sensitive": false,
          "description": "Progesterone receptor status. Record status regardless of any qualifying statements, e.g. weakly positive. This is collected for invasive breast tumours only."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "ERSTATUS",
          "sensitive": false,
          "description": "OESTROGEN RECEPTOR STATUS Record status regardless of any qualifying statements, e.g. weakly positive.\nThis is collected for invasive breast tumours only."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "GRADE_CELL_TYPE_MINOR",
          "sensitive": false,
          "description": "GLEASON MINOR Valid for all C61X prostate cancers with incidence date 01/01/2011 onwards.  Records for different types of tumour or with earlier incidence dates should return blanks."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "GLEASON_MAJOR",
          "sensitive": false,
          "description": "1 = Score total 1\n2 = Score total 2\n3 = Score total 3\n4 = Score total 4\n5 = Score total 5\n9 = Not known."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "GRADE_CELL_TYPE_TERTIARY",
          "sensitive": false,
          "description": "GLEASON TERTIARY Valid for all C61X prostate cancers with incidence date 01/01/2011 onwards.  Records for different types of tumour or with earlier incidence dates should return blanks. This indicates a generally more aggressive pattern of tumour. Codes as per 'Gleason Major'."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TRANSFORMATION_DATE",
          "sensitive": false,
          "description": "Data is collected for haematological malignancies that are deemed to have transformed. (Guidelines from ENCR European Network of Cancer Registries) Date is collected from 01.01.2013."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TRANSFORMATION_ICD10",
          "sensitive": false,
          "description": "Denotes the classification of the disease of the transformation (haematological malignancies that are deemed to have transformed). It comprises a code from ICD10 classification. Data is collected from 01.01.2013 with the ICD10 codes C810– D479."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TRANSFORMATION_ICDO3",
          "sensitive": false,
          "description": "Indicates the morphology (histology) and behaviour of the transformation (i.e. haematological malignancies that are deemed to have transformed). It comprises the first four digits of the ICD03 (ICDO3 International Classification of Diseases for Oncology (3rd revision)) morphology code with a fifth digit which denotes behaviour. Data available from 01.01.2013. ICDO3 codes from 95903 to 99923"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "LUNG_TNM8",
          "sensitive": false,
          "description": "For look-up purposes only. Indicates if TNM version 8 has been recorded. From 01.01.2017"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "CLINICAL_TUMOUR_SIZE",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Clinical tumour size is the maximum diameter in mm of the invasive component of the tumour collected for all malignant hepatocellular tumours of the liver (ICD10 C220) with an incidence date from 1.1.2014"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "AJCC",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. AJCC – American Joint Committee on Cancer indicates the extent of disease progression of invasive melanoma (C43) tumours from 1.1.2015"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "STAGING_GROUP",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. This staging group indicates the extent of disease progression of invasive testicular tumours with an incidence date from 1.1.2014"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "PSA_LEVEL",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. This field applies to prostate cancer only (C61X) with an incidence date from 1.1.2017. This is a numeric value between 0.1 – 9999999.9 and not known set to 0."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "SERUM_MARKER",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. This denotes the nadir levels as obtained after orchidectomy. This applies to testicular cancers only (C62#) with an incidence date from 1.1.2017"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "PERFORMANCE_STATUS",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Performance status is an overall assessment of the functional/physical performance of the patient. This field applies to all registerable invasive cancers C000 – C97X (excluding non melanoma skin C44) and brain cancers D180, D32*, D33*, D352, D353, D354 with an incidence date from 1.1.2017"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "NO_TREATMENT_REASON",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. This is the reason why no treatment has taken place. It applies to all registerable cancers with an incidence date from 1.1.2017. This is only to be completed if no treatment has taken place."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "PALLIATIVE_SURGERY",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Treated with palliative Surgery from 01.01.2016"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_PAL_SURGERY",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Date treated with palliative Surgery from 01.01.2016"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TYPE_OTHER_THERAPY_TYPE",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. This field was previously text only and was collected for all registrations with an incidence date from 1.1.1997. This field changed to a dropdown option for registrations from 1.1.2016"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TYPE_IMMUN_TYPE",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Indicates if immunitherapy/biotherapy was administered. From 01.01.1997"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "DATE_1ST_IMMUN_TYPE",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Date treated with immuno/bio therapy"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "TYPE_RADIO_TYPE",
          "sensitive": false,
          "description": "Variable added to the file during June 2018. Type of radiotherapy administered from 01.01.2006"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "THERAPY_OBJECTIVES",
          "sensitive": false,
          "description": "Intent is most likely to be curative in early stage of disease e.g. microinvasive, or non invasive, in situ disease, T1 or T2 N0 M0 , node negative breast cancer, Dukes’ A colorectal cancer, FIGO I cervical cancer. Intent unlikely to be curative in advanced disease e.g. M1 breast cancer, Dukes’ D, FIGO IV. \nOptions: Code Description 1 Curative intent 2 Non-curative intent (Palliative) 9 Not Known This field is collected for all registrations with a Scottish incidence date from 1.1.1997."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_GP_DIAG",
          "sensitive": false,
          "description": "Hospital of diagnosis denotes the location (institution) code of the hospital in which the diagnosis was first made. This may also be a GP surgery code if an initial biopsy was taken by a GP. This field is collected for all registrations with a Scottish incidence date from 1.1.1997."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_GP_1ST_SURGERY",
          "sensitive": false,
          "description": "Institution code/practice code of Hospital/GP practice where a surgical treatment was first carried out (if applicable)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_1ST_RAD",
          "sensitive": false,
          "description": "Institution code of Hospital where Radiotherapy was first carried out (if applicable)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_GP_1ST_CHEMO",
          "sensitive": false,
          "description": "Institution code/practice code of Hospital/GP practice of first Chemotherapy (if applicable)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_GP_1ST_HORMONE_THERAPY",
          "sensitive": false,
          "description": "Institution code/practice code of Hospital/GP practice initiating Hormone Therapy (if applicable)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_GP_1ST_OTHER_THERAPY",
          "sensitive": false,
          "description": "Institution code/practice code of Hospital/GP surgery where Other Therapy was first carried out (if applicable)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HOSP_GP_1ST_PAL_SURGERY",
          "sensitive": false,
          "description": "Institution code/practice code of Hospital/GP practice where a palliative surgical treatment was first carried out (if applicable)"
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBRES_CURRENT",
          "sensitive": false,
          "description": "Patient's NHS Scotland Health Board of Residence according to HB configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBDIAG_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where diagnosis took place according to configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBSURG_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where surgical treatment took place according to configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBRAD_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where Radiotherapy took place according to configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBCHEMO_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where Chemotherapy took place according to configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBHORM_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where Hormone Therapy took place according to configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBPAL_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where palliative surgical treatment took place according to configuration as at current date."
        }
      ]
    },
    {
      "name": "SMR06",
      "columns": [
        {
          "name": "HBIMMUN_CURRENT",
          "sensitive": false,
          "description": "NHS Scotland Health Board where immuno/bio therapy took place according to configuration as at current date."
        }
      ]
    }
  ],
  "tissuesSampleCollection": [
    {
      "materialType": "None/not available"
    }
  ]
}